168 related articles for article (PubMed ID: 26658239)
21. Lipoprotein subclasses determined by nuclear magnetic resonance spectroscopy and coronary atherosclerosis in patients with rheumatoid arthritis.
Chung CP; Oeser A; Raggi P; Sokka T; Pincus T; Solus JF; Linton MF; Fazio S; Stein CM
J Rheumatol; 2010 Aug; 37(8):1633-8. PubMed ID: 20516025
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of low-density lipoprotein particle number distribution in patients with type 2 diabetes mellitus with low-density lipoprotein cholesterol <50 mg/dl and non-high-density lipoprotein cholesterol <80 mg/dl.
Malave H; Castro M; Burkle J; Voros S; Dayspring T; Honigberg R; Pourfarzib R
Am J Cardiol; 2012 Sep; 110(5):662-5. PubMed ID: 22621796
[TBL] [Abstract][Full Text] [Related]
23. Dose-dependent action of atorvastatin in type IIB hyperlipidemia: preferential and progressive reduction of atherogenic apoB-containing lipoprotein subclasses (VLDL-2, IDL, small dense LDL) and stimulation of cellular cholesterol efflux.
Guerin M; Egger P; Soudant C; Le Goff W; van Tol A; Dupuis R; Chapman MJ
Atherosclerosis; 2002 Aug; 163(2):287-96. PubMed ID: 12052475
[TBL] [Abstract][Full Text] [Related]
24. Effects of marine n-3 fatty acid supplementation on lipoprotein subclasses measured by nuclear magnetic resonance in subjects with type II diabetes.
Mostad IL; Bjerve KS; Lydersen S; Grill V
Eur J Clin Nutr; 2008 Mar; 62(3):419-29. PubMed ID: 17327864
[TBL] [Abstract][Full Text] [Related]
25. Sex and age differences in lipoprotein subclasses measured by nuclear magnetic resonance spectroscopy: the Framingham Study.
Freedman DS; Otvos JD; Jeyarajah EJ; Shalaurova I; Cupples LA; Parise H; D'Agostino RB; Wilson PW; Schaefer EJ
Clin Chem; 2004 Jul; 50(7):1189-200. PubMed ID: 15107310
[TBL] [Abstract][Full Text] [Related]
26. Apolipoprotein-defined and NMR lipoprotein subclasses in the veterans affairs diabetes trial.
Azar M; Lyons TJ; Alaupovic P; Stoner JA; Quiroga C; Kaufman DG; Lopes-Virella M; Klein RL; Jenkins AJ;
J Diabetes Complications; 2013; 27(6):627-32. PubMed ID: 23911536
[TBL] [Abstract][Full Text] [Related]
27. Effects of pravastatin treatment on lipoprotein subclass profiles and particle size in the PLAC-I trial.
Otvos JD; Shalaurova I; Freedman DS; Rosenson RS
Atherosclerosis; 2002 Jan; 160(1):41-8. PubMed ID: 11755921
[TBL] [Abstract][Full Text] [Related]
28. HIV/hepatitis C virus coinfection ameliorates the atherogenic lipoprotein abnormalities of HIV infection.
Wheeler AL; Scherzer R; Lee D; Delaney JA; Bacchetti P; Shlipak MG; Sidney S; Grunfeld C; Tien PC;
AIDS; 2014 Jan; 28(1):49-58. PubMed ID: 24136113
[TBL] [Abstract][Full Text] [Related]
29. Association between proprotein convertase subtilisin/kexin 9 (PCSK9) and lipoprotein subclasses in children with type 1 diabetes mellitus: Effects of glycemic control.
Bojanin D; Vekic J; Milenkovic T; Vukovic R; Zeljkovic A; Stefanovic A; Janac J; Ivanisevic J; Mitrovic K; Miljkovic M; Spasojevic-Kalimanovska V
Atherosclerosis; 2019 Jan; 280():14-20. PubMed ID: 30453116
[TBL] [Abstract][Full Text] [Related]
30. Low-density lipoprotein particle size, triglyceride-rich lipoproteins, and glucose tolerance in non-diabetic men with essential hypertension.
Rubies-Prat J; Ordóñez-Llanos J; Martin S; Blanco-Vaca F; Molina L; Goday A; Pedro-Botet J
Clin Exp Hypertens; 2001 Aug; 23(6):489-500. PubMed ID: 11478431
[TBL] [Abstract][Full Text] [Related]
31. Lipoprotein composition in insulin-dependent diabetes mellitus with chronic renal failure: effect of kidney and pancreas transplantation.
Hughes TA; Gaber AO; Amiri HS; Wang X; Elmer DS; Winsett RP; Hathaway DK; Hughes SM; Ghawji M
Metabolism; 1994 Mar; 43(3):333-47. PubMed ID: 8139482
[TBL] [Abstract][Full Text] [Related]
32. High-density lipoprotein subclasses in diabetes.
Bergman M; Gidez LI; Eder HA
Am J Med; 1986 Sep; 81(3):488-92. PubMed ID: 3529955
[TBL] [Abstract][Full Text] [Related]
33. Primary aldosteronism is associated with decreased low-density and high-density lipoprotein particle concentrations and increased GlycA, a pro-inflammatory glycoprotein biomarker.
Berends AMA; Buitenwerf E; Gruppen EG; Sluiter WJ; Bakker SJL; Connelly MA; Kerstens MN; Dullaart RPF
Clin Endocrinol (Oxf); 2019 Jan; 90(1):79-87. PubMed ID: 30372543
[TBL] [Abstract][Full Text] [Related]
34. Extended-release niacin/laropiprant effects on lipoprotein subfractions in patients with type 2 diabetes mellitus.
Bays H; Giezek H; McKenney JM; O'Neill EA; Tershakovec AM
Metab Syndr Relat Disord; 2012 Aug; 10(4):260-6. PubMed ID: 22400810
[TBL] [Abstract][Full Text] [Related]
35. Effect of intensive diabetes treatment on low-density lipoprotein apolipoprotein B kinetics in type I diabetes.
Rosenstock J; Vega GL; Raskin P
Diabetes; 1988 Apr; 37(4):393-7. PubMed ID: 3288528
[TBL] [Abstract][Full Text] [Related]
36. Lipoprotein Particle Profiles, Standard Lipids, and Peripheral Artery Disease Incidence.
Aday AW; Lawler PR; Cook NR; Ridker PM; Mora S; Pradhan AD
Circulation; 2018 Nov; 138(21):2330-2341. PubMed ID: 30021845
[TBL] [Abstract][Full Text] [Related]
37. Atherogenic lipoprotein particle size and concentrations and the effect of pravastatin in children with familial hypercholesterolemia.
van der Graaf A; Rodenburg J; Vissers MN; Hutten BA; Wiegman A; Trip MD; Stroes ES; Wijburg FA; Otvos JD; Kastelein JJ
J Pediatr; 2008 Jun; 152(6):873-8. PubMed ID: 18492534
[TBL] [Abstract][Full Text] [Related]
38. Lipoprotein composition in NIDDM: effects of dietary oleic acid on the composition, oxidisability and function of low and high density lipoproteins.
Dimitriadis E; Griffin M; Collins P; Johnson A; Owens D; Tomkin GH
Diabetologia; 1996 Jun; 39(6):667-76. PubMed ID: 8781762
[TBL] [Abstract][Full Text] [Related]
39. Data on carotid intima-media thickness and lipoprotein subclasses in type 1 diabetes from the Diabetes Control and Complications Trial and the Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC).
Basu A; Jenkins AJ; Zhang Y; Stoner JA; Klein RL; Lopes-Virella MF; Timothy Garvey W; Lyons TJ;
Data Brief; 2016 Mar; 6():33-8. PubMed ID: 26759826
[TBL] [Abstract][Full Text] [Related]
40. Gemfibrozil reduces small low-density lipoprotein more in normolipemic subjects classified as low-density lipoprotein pattern B compared with pattern A.
Superko HR; Berneis KK; Williams PT; Rizzo M; Wood PD
Am J Cardiol; 2005 Nov; 96(9):1266-72. PubMed ID: 16253595
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
